Market Chatter: Gritstone bio in Talks for Funding Amid Bankruptcy Proceedings

MT Newswires Live10-17

Gritstone bio (GRTS) is in talks for funding and has held "some conversations" with potential bankruptcy plan sponsors, Bloomberg News reported Wednesday, citing Debra Grassgreen, a legal representative for the firm.

The company filed for bankruptcy last week and Bloomberg said the remarks were made during a Wednesday court hearing, where a US bankruptcy judge approved Gritstone bio's request to use cash collateral to pay salaries and its vendors.

According to the report, court records showed that Gritstone bio has not yet secured post-petition financing.

Gritstone bio did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment